Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer

Clinical trial NCT07401537 · RECRUITING

Trial details

NCT number: NCT07401537
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple -Negative Breast Cancer Breast Cancer

Start date: 2025-12-31
Primary completion: 2028-12-31
Enrollment: 416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.